Balaji Amines Ltd
Incorporate in 1989, Balaji Amines Ltd is engaged in manufacturing of specialty chemicals, aliphatic amines, and derivatives, along with ownership of a five-star hotel in Solapur, Maharashtra.[1]
- Market Cap ₹ 7,668 Cr.
- Current Price ₹ 2,366
- High / Low ₹ 2,444 / 905
- Stock P/E 45.9
- Book Value ₹ 610
- Dividend Yield 0.46 %
- ROCE 11.0 %
- ROE 8.74 %
- Face Value ₹ 2.00
Pros
- Company is almost debt free.
- Company has been maintaining a healthy dividend payout of 20.4%
- Company's working capital requirements have reduced from 101 days to 68.8 days
Cons
- Stock is trading at 3.88 times its book value
- The company has delivered a poor sales growth of 1.64% over past five years.
- Company has a low return on equity of 9.92% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 616 | 640 | 668 | 858 | 940 | 935 | 1,308 | 2,314 | 2,346 | 1,631 | 1,389 | 1,419 | |
| 515 | 514 | 519 | 676 | 747 | 754 | 935 | 1,691 | 1,736 | 1,308 | 1,157 | 1,154 | |
| Operating Profit | 102 | 127 | 149 | 182 | 193 | 181 | 373 | 623 | 609 | 324 | 232 | 265 |
| OPM % | 17% | 20% | 22% | 21% | 21% | 19% | 29% | 27% | 26% | 20% | 17% | 19% |
| 4 | 3 | 9 | 12 | 4 | 5 | 6 | 15 | 15 | 30 | 33 | 29 | |
| Interest | 35 | 22 | 13 | 9 | 13 | 23 | 18 | 17 | 12 | 6 | 4 | 5 |
| Depreciation | 20 | 19 | 20 | 19 | 20 | 32 | 34 | 42 | 46 | 45 | 48 | 56 |
| Profit before tax | 51 | 88 | 126 | 166 | 165 | 131 | 327 | 578 | 567 | 302 | 213 | 232 |
| Tax % | 35% | 34% | 34% | 32% | 29% | 26% | 25% | 28% | 28% | 23% | 26% | 27% |
| 33 | 58 | 82 | 113 | 117 | 97 | 243 | 418 | 406 | 232 | 159 | 169 | |
| EPS in Rs | 10.25 | 17.78 | 25.42 | 34.93 | 36.27 | 32.34 | 73.51 | 113.71 | 100.47 | 63.22 | 48.62 | 51.60 |
| Dividend Payout % | 12% | 11% | 9% | 7% | 8% | 10% | 5% | 5% | 10% | 17% | 23% | 21% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 2% |
| 3 Years: | -15% |
| TTM: | 2% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | -7% |
| 3 Years: | -20% |
| TTM: | 6% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 24% |
| 5 Years: | -5% |
| 3 Years: | 3% |
| 1 Year: | 37% |
| Return on Equity | |
|---|---|
| 10 Years: | 18% |
| 5 Years: | 16% |
| 3 Years: | 10% |
| Last Year: | 9% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 |
| Reserves | 221 | 274 | 356 | 461 | 568 | 652 | 888 | 1,243 | 1,548 | 1,715 | 1,839 | 1,970 |
| 256 | 173 | 105 | 152 | 227 | 260 | 127 | 101 | 58 | 20 | 11 | 133 | |
| 139 | 152 | 168 | 229 | 244 | 195 | 289 | 395 | 351 | 405 | 396 | 633 | |
| Total Liabilities | 623 | 605 | 635 | 848 | 1,046 | 1,113 | 1,310 | 1,745 | 1,963 | 2,146 | 2,252 | 2,743 |
| 341 | 341 | 325 | 316 | 320 | 573 | 543 | 681 | 780 | 896 | 1,003 | 1,043 | |
| CWIP | 3 | 16 | 25 | 123 | 269 | 46 | 173 | 141 | 113 | 205 | 238 | 512 |
| Investments | 0 | 0 | 0 | 0 | 0 | 48 | 0 | 0 | 73 | 0 | 0 | 0 |
| 278 | 248 | 284 | 409 | 457 | 446 | 594 | 923 | 996 | 1,046 | 1,011 | 1,188 | |
| Total Assets | 623 | 605 | 635 | 848 | 1,046 | 1,113 | 1,310 | 1,745 | 1,963 | 2,146 | 2,252 | 2,743 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 56 | 85 | 60 | 140 | 94 | 144 | 110 | 220 | 354 | 334 | 255 | 184 | |
| -4 | -29 | -10 | -135 | -119 | -130 | -62 | -147 | -210 | -274 | -139 | -344 | |
| -55 | -54 | -55 | 16 | 21 | -26 | -37 | -57 | -81 | -75 | -49 | 85 | |
| Net Cash Flow | -3 | 2 | -5 | 21 | -4 | -12 | 11 | 16 | 63 | -15 | 68 | -75 |
| Free Cash Flow | 48 | 53 | 47 | 32 | -75 | 83 | -21 | 72 | 234 | 82 | 69 | -186 |
| CFO/OP | 65% | 77% | 58% | 101% | 74% | 108% | 40% | 56% | 81% | 123% | 128% | 82% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 71 | 71 | 68 | 73 | 65 | 81 | 85 | 93 | 59 | 71 | 72 | 89 |
| Inventory Days | 114 | 80 | 106 | 70 | 116 | 77 | 64 | 66 | 89 | 116 | 128 | 113 |
| Days Payable | 48 | 58 | 55 | 56 | 60 | 42 | 44 | 54 | 18 | 31 | 32 | 39 |
| Cash Conversion Cycle | 136 | 93 | 119 | 87 | 120 | 116 | 104 | 105 | 129 | 156 | 168 | 163 |
| Working Capital Days | 7 | 12 | 42 | 31 | 47 | 55 | 88 | 88 | 89 | 114 | 120 | 69 |
| ROCE % | 18% | 23% | 30% | 32% | 24% | 18% | 35% | 49% | 36% | 17% | 11% | 11% |
Insights
In beta| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Export Revenue Share % ・Standalone data |
|
||||||
| Installed Capacity MTPA ・Standalone data |
|||||||
| Hotel Occupancy Rate % ・Standalone data |
|||||||
| Hotel RevPAR Rs ・Standalone data |
|||||||
Extracted by Screener AI
Documents
Announcements
-
Board Meeting Intimation for Considering And Approving The Un-Audited Standalone And Consolidated Financial Results Of The Company For Quarter Ended 30Th June, 2026
17 Jul - Board meets on 27 July 2026 to approve Q1 FY27 standalone and consolidated results; trading window remains closed.
- Shareholder Meeting / Postal Ballot-Scrutinizer''s Report 13 Jul
- Shareholder Meeting / Postal Ballot-Outcome of AGM 10 Jul
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
3 Jul - Certificate under Regulations 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for Quarter Ended 30th June, 2026
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
2 Jul - Newspaper Advertisement Regarding 2nd 100 days Saksham Niveshak Campaign and Special Window for Transfer and Dematerialisation of Physical Shares.
Annual reports
-
Financial Year 2026
from bse
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
Concalls
-
May 2026Transcript PPT REC
-
Jan 2026TranscriptAI SummaryPPT
-
Nov 2025Transcript PPT
-
Aug 2025TranscriptAI SummaryPPT
-
Jun 2025Transcript PPT
-
Feb 2025TranscriptAI SummaryPPT
-
Nov 2024Transcript PPT REC
-
Aug 2024TranscriptAI SummaryPPT
-
May 2024TranscriptPPT
-
May 2024Transcript PPT
-
Feb 2024TranscriptAI SummaryPPT
-
Nov 2023Transcript PPT
-
Sep 2023Transcript PPT
-
May 2023Transcript PPT
-
Feb 2023TranscriptAI SummaryPPT
-
Oct 2022TranscriptAI SummaryPPT
-
Aug 2022TranscriptAI SummaryPPT
-
May 2022Transcript PPT
-
Feb 2022Transcript PPT
-
Nov 2021Transcript PPT
-
Aug 2021Transcript PPT
-
Jun 2021Transcript PPT
-
Feb 2021Transcript PPT
-
Nov 2020Transcript PPT
-
Aug 2020Transcript PPT
-
Jul 2020Transcript PPT
-
Feb 2020Transcript PPT
-
Jan 2020TranscriptAI SummaryPPT
-
Dec 2019Transcript PPT
-
Nov 2019TranscriptAI SummaryPPT
-
Aug 2019Transcript PPT
-
Jul 2019TranscriptAI SummaryPPT
-
May 2019TranscriptPPT
-
Aug 2018TranscriptPPT
-
May 2018TranscriptPPT
-
Feb 2018TranscriptPPT
-
Feb 2017TranscriptPPT
-
Feb 2017TranscriptPPT
Market Leadership[1]
The Company is the largest manufacturer of aliphatic amines and methylamines in India, the only domestic company to develop indigenous amines manufacturing technology, and the sole Indian producer of several specialty chemicals